VERO BIOTECH INC Company Profile
✉ Email this page to a colleague
What is the competitive landscape for VERO BIOTECH INC, and what generic alternatives to VERO BIOTECH INC drugs are available?
VERO BIOTECH INC has one approved drug.
There are twenty-four US patents protecting VERO BIOTECH INC drugs.
There are sixty patent family members on VERO BIOTECH INC drugs in five countries and two supplementary protection certificates in two countries.
Summary for VERO BIOTECH INC
International Patents: | 60 |
US Patents: | 24 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Drugs and US Patents for VERO BIOTECH INC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vero Biotech Inc | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | RX | Yes | Yes | 11,383,059 | ⤷ Sign Up | ⤷ Sign Up | ||||
Vero Biotech Inc | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | RX | Yes | Yes | 10,737,051 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Vero Biotech Inc | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | RX | Yes | Yes | 7,560,076 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Vero Biotech Inc | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | RX | Yes | Yes | 9,604,028 | ⤷ Sign Up | ⤷ Sign Up | ||||
Vero Biotech Inc | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | RX | Yes | Yes | 7,618,594 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Vero Biotech Inc | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | RX | Yes | Yes | 10,926,054 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VERO BIOTECH INC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Vero Biotech Inc | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | 6,758,214 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for VERO BIOTECH INC Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
World Intellectual Property Organization (WIPO) | 2010151505 | ⤷ Sign Up |
Japan | 5901684 | ⤷ Sign Up |
Japan | 2012179365 | ⤷ Sign Up |
Japan | 5529871 | ⤷ Sign Up |
Japan | 2015006422 | ⤷ Sign Up |
Japan | 2022078116 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for VERO BIOTECH INC Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0786264 | SPC/GB08/019 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: NITRIC OXIDE (NO); REGISTERED: UK EU/1/01/194/001 20010801 |
0560928 | 2002C/003 | Belgium | ⤷ Sign Up | PRODUCT NAME: NITRIC OXIDE; REGISTRATION NO/DATE: EU/1/01/194/001 20010801 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.